Generic opioids gain momentum against brand-name drugmakers | Employers weigh health insurance options | Doctor-patient communication plays role in drug adherence
Web Version
 
 
January 2, 2013
FOLLOW PCMA ON TWITTER  Twitter
PCMA SmartBrief
News for the PBM Industry
SIGN UP|FORWARD|ARCHIVE

Featured Story
Generic opioids gain momentum against brand-name drugmakers
Brand-name drugmakers behind the narcotic painkillers Opana and OxyContin appear to be losing their bid to prevent the introduction of the drugs' cheaper generic versions. "We understand the value in developing appropriate abuse-resistant technology, and we want to find a way of incentivizing that," said Dr. Douglas Throckmorton of the FDA. "But we also understand the value of generics for patients." The New York Times (tiered subscription model) (1/1)
Share: LinkedInTwitterFacebookGoogle+Email
Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
Advertisement
 
Legislative & Regulatory News
Employers weigh health insurance options
Employers must decide whether to continue offering health insurance to their employees or pay a penalty and have workers find their own coverage through exchanges. The Affordable Care Act requires employers with 50 or more employees to offer health insurance for full-time workers beginning in 2014. The Wall Street Journal (tiered subscription model) (1/1)
Share: LinkedInTwitterFacebookGoogle+Email
Doctor-patient communication plays role in drug adherence
Doctors who establish a good, trusting relationship with patients may be able to help improve adherence to prescriptions, a study in JAMA Internal Medicine suggests. Data on 9,377 patients using blood glucose, blood pressure or cholesterol drugs showed 30% may not have been following prescribed directions for medication use, but that number fell 4% to 6% among patients who reported having better communication with their physicians. Modern Healthcare (subscription required) (12/31)
Share: LinkedInTwitterFacebookGoogle+Email
PBM Industry News
Congress works out Tricare changes
To reduce costs, senior beneficiaries will fill prescriptions for chronic conditions through mail-service or base pharmacies under changes to the Tricare health insurance program. The Sun Herald (Biloxi-Gulfport, Miss.) (12/29)
Share: LinkedInTwitterFacebookGoogle+Email
Drug Industry Spotlight
Differences between branded drugs, generics may reduce adherence
Differences in color and shape between branded drugs and their generic counterparts may be connected with prescription nonadherence, according to a controlled study published in the Archives of Internal Medicine. "Changes between generic products with different physical characteristics may cause confusion and result in reduced adherence or prescription error," researchers wrote. "... Taking steps to permit (or even require) similarity in pill appearance among bioequivalent brand-name and generic drugs may offer another way to achieve better patient adherence to essential medication regimens." Medscape (free registration) (12/31)
Share: LinkedInTwitterFacebookGoogle+Email
Mylan receives FDA nod for generic seizure drug
The FDA has granted Mylan Pharmaceuticals approval for its chewable phenytoin tablets in 50 mg strength to address seizures, including during and after neurosurgery. The drug is a generic formulation of Pfizer's Dilantin tablets. Drug Store News (12/28)
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
Birds sing after a storm; why shouldn't people feel as free to delight in whatever remains to them."
-- Rose Kennedy,
American philanthropist
Share: LinkedInTwitterFacebookGoogle+Email
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 216 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
(202) 207-3610
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Melissa Turner
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information